David Schairer • UCSD Profiles (original) (raw)

  1. Dual dysregulation of TNF/interferon signaling and classical monocytes are implicated in Reactive Infectious Mucocutaneous Eruptions. JCI Insight. 2025 Nov 20. Tan Z, Wu G, Salgado Figueroa D, Dutta P, Jaeger Z, Mazurie M, Schairer D, Eichenfield D, Tom WL, Galli L, Eichenfield L, Geng B, Hinds B, Hoffman HM, Broderick L, Croker B, Ay F, Oldenburg R. PMID: 41264360.
    View in: PubMed Mentions: Fields:
  2. Glomulin and cerebral cavernous malformations 2 protein-like mutations in an extensive blaschkoid glomuvenous malformation with polydactyly. JAAD Case Rep. 2025 Sep; 63:139-142. Roso-Mares A, Andújar Perez I, Schairer DO, Sun BK. PMID: 40894452; PMCID: PMC12391566.
    View in: PubMed Mentions:
  3. A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study. J Am Acad Dermatol. 2023 Nov; 89(5):1041-1044. Lee SS, Kaushik A, Natsis N, Kusari A, Schairer D, Lindback S, Levenberg M, Mills JR, Peeples K, Smith R, Eichenfield LF. PMID: 37516950.
    View in: PubMed Mentions: Fields:
  4. Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus. Pediatr Dermatol. 2022 Nov; 39(6):985-986. Osmani S, Schairer DO. PMID: 36047838.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCells
  5. Atopic Dermatitis: New Developments. Dermatol Clin. 2019 Jan; 37(1):11-20. Kusari A, Han AM, Schairer D, Eichenfield LF. PMID: 30466683.
    View in: PubMed Mentions: 18 Fields:
    Translation:HumansPHPublic Health
  6. Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin. Precis Nanomed. 2018 Oct; 1(3):173-182. Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ. PMID: 31032494; PMCID: PMC6483385.
    View in: PubMed Mentions: 6
  7. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018 Aug; 57(8):1001-1006. Guzman AK, Schairer DO, Garelik JL, Cohen SR. PMID: 29904968.
    View in: PubMed Mentions: 14 Fields:
    Translation:Humans
  8. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018 03; 78(3 Suppl 1):S53-S62. Cotter DG, Schairer D, Eichenfield L. PMID: 29248518.
    View in: PubMed Mentions: 38 Fields:
    Translation:HumansAnimals
  9. Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1448-1450. Iammatteo M, Akenroye A, Jariwala S, Lee B, Schairer D, Rosenstreich D. PMID: 28396110.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  10. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus. J Invest Dermatol. 2015 Aug; 135(8):1986-1995. Doerner JL, Wen J, Xia Y, Paz KB, Schairer D, Wu L, Chalmers SA, Izmirly P, Michaelson JS, Burkly LC, Friedman AJ, Putterman C. PMID: 25826425; PMCID: PMC4504782.
    View in: PubMed Mentions: 30 Fields:
    Translation:AnimalsCells
  11. Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing. J Invest Dermatol. 2015 Sep; 135(9):2309-2318. Charafeddine RA, Makdisi J, Schairer D, O'Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ. PMID: 25756798; PMCID: PMC4537388.
    View in: PubMed Mentions: 32 Fields:
    Translation:AnimalsCells
  12. Evaluation of the antibiotic properties of glutathione. J Drugs Dermatol. 2013 Nov; 12(11):1272-7. Schairer DO, Chouake JS, Kutner AJ, Makdisi J, Nosanchuk JD, Friedman AJ. PMID: 24196336.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansAnimalsCells
  13. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler. 2014 Apr; 20(5):610-6. Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA, Gromisch ES, Schairer D. PMID: 23999609.
    View in: PubMed Mentions: 42 Fields:
    Translation:Humans
  14. Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomedicine. 2014 Jan; 10(1):269-77. Sanchez DA, Schairer D, Tuckman-Vernon C, Chouake J, Kutner A, Makdisi J, Friedman JM, Nosanchuk JD, Friedman AJ. PMID: 23770066.
    View in: PubMed Mentions: 27 Fields:
    Translation:HumansAnimals
  15. Cantharidin therapy: practice patterns and attitudes of health care providers. J Am Acad Dermatol. 2013 Jun; 68(6):1045-6. Pompei DT, Rezzadeh KS, Viola KV, Lee DH, Schairer DO, Chismar LA, Cohen SR. PMID: 23680201.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  16. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. J Drugs Dermatol. 2012 Dec; 11(12):1471-7. Chouake J, Schairer D, Kutner A, Sanchez DA, Makdisi J, Blecher-Paz K, Nacharaju P, Tuckman-Vernon C, Gialanella P, Friedman JM, Nosanchuk JD, Friedman AJ. PMID: 23377518.
    View in: PubMed Mentions: 10 Fields:
    Translation:AnimalsCells
  17. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatol. 2013 May; 133(5):1231-9. Friedman AJ, Phan J, Schairer DO, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL, Kim J. PMID: 23190896; PMCID: PMC3631294.
    View in: PubMed Mentions: 89 Fields:
    Translation:HumansCells
  18. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012 May 01; 3(3):271-9. Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. PMID: 22546899; PMCID: PMC3442839.
    View in: PubMed Mentions: 203 Fields:
  19. Psychology and psychiatry in the dermatologist's office: an approach to delusions of parasitosis. J Drugs Dermatol. 2012 Apr; 11(4):543-5. Schairer D, Schairer L, Friedman A. PMID: 22453598.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  20. Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine. 2012 Nov; 8(8):1364-71. Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ. PMID: 22406184.
    View in: PubMed Mentions: 32 Fields:
    Translation:Animals
  21. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence. 2012 Jan-Feb; 3(1):62-7. Schairer D, Martinez LR, Blecher K, Chouake J, Nacharaju P, Gialanella P, Friedman JM, Nosanchuk JD, Friedman A. PMID: 22286699; PMCID: PMC3337151.
    View in: PubMed Mentions: 22 Fields:
    Translation:HumansAnimalsCells
  22. Manifestations and treatment of cutaneous lupus erythematosus (Part II of II). J Drugs Dermatol. 2011 Dec; 10(12):1474-6. Schairer D, Friedman A. PMID: 22134575.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  23. Letter to the editor--atrial fibrillation: an inflammatory and autoimmune disorder. Heart Rhythm. 2012 Feb; 9(2):e2; author reply e2-3. Schairer DO, Levis WR. PMID: 22100332.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  24. Manifestations and treatment of cutaneous lupus erythematosus (part I of II). J Drugs Dermatol. 2011 Oct; 10(10):1212-4. Schairer D, Friedman A. PMID: 21968677.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  25. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide. 2011 Nov 30; 25(4):381-6. Friedman AJ, Blecher K, Schairer D, Tuckman-Vernon C, Nacharaju P, Sanchez D, Gialanella P, Martinez LR, Friedman JM, Nosanchuk JD. PMID: 21946032.
    View in: PubMed Mentions: 19 Fields:
    Translation:Cells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs